-
Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug
06 Aug 2025 02:36 GMT
… ) -- Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to benefit … the first new type of painkiller to reach the US … .
The company is also developing the pill, a safer … .
The drugmaker said it would conduct a second trial of Journavx …
-
Trial Failure of Vertex’s Next-Gen Pain Drug Mars Strong Q2 Earnings
06 Aug 2025 04:28 GMT
… Vertex Pharmaceuticals’ pipeline of non-opioid painkillers failed its Phase II trial, … compared with placebo.
The trial tested the drug in three … executives said that the FDA appeared not to be inclined … plans to discontinue the development of VX-993 in …
-
Kyoto Researchers Develop Non-Addictive Morphine Alternative
06 Aug 2025 04:37 GMT
… This development, emerging from Japan’s rigorous pharmaceutical research … traditional opioids. Early trials indicate it provides relief … molecular level, the painkiller operates via selective ion … Japan’s accelerated pharmaceutical pathways.
Industry insiders …
-
Teva shifts popular painkiller production to Germany, updates packaging
06 Aug 2025 03:28 GMT
Teva Pharmaceutical Industries said it will stop producing its widely used painkiller Acamol … . The shelf version sold in pharmacies will shrink from 14 to … 10 capsules, while the pharmacy-counter version will expand from …
-
Researchers Uncover 5,000 AI-Driven Fake Pharmacy Sites Selling Counterfeits
06 Aug 2025 04:27 GMT
… 5,000 counterfeit pharmacy websites peddling potentially … masquerading as legitimate online pharmacies, employ advanced tactics … sold—ranging from counterfeit painkillers to unapproved erectile … Boards of Pharmacy’s Verified Internet Pharmacy Practice Sites …
-
Vertex’s top scientist Altshuler to retire, next-generation pain drug fails
05 Aug 2025 01:45 GMT
-
FDA updates opioid pain medication labeling requirements
04 Aug 2025 19:18 GMT
… safety labeling for all opioid pain medications. Following the results of two … that continued use of opioid pain medications is associated with increased risks …
-
After phase 3 hit, Spine seeks path forward for pain drug
04 Aug 2025 15:37 GMT
The first phase 3 readout with Spine BioPharma's drug candidate for chronic low back pain (CLBP) has proved disappointing, but the company still believes there is a way forward for the programme.
The MODEL trial of Spine's vicatertide (SB-01), a …
-
Kyoto Univ. Team Develops Pain Reliever Comparable to Morphine
05 Aug 2025 01:34 GMT
… Kyoto University research team has developed a pain-reliever that is … team, the newly developed drug, Adriana, is a groundbreaking painkiller, which works …
-
Vertex to stop developing new painkiller as solo treatment after mid-stage study setback
04 Aug 2025 21:22 GMT
… -Vertex Pharmaceuticals said on Monday it will not continue development of … its experimental non-opioid painkiller as … the results of this trial that would help … opioid Journavx, bolstering its pain drug treatments.
The company tested …
About
© 1995-2025